Isolating lead therapeutic antibody candidates in less time

Developing novel therapeutic antibodies requires rapid construction and testing of candidate molecules. High quality, affordable recombinant antibodies are critical for assessing developability and eliminating variants with lower performance before moving to more resource-intensive stages for final lead candidate selection.

Explore services for antibody engineering in our resource guide.

Download guide

Therapeutic antibody development workflow includes discovery and target ID, library generation, lead ID and verification, lead optimization, safety and toxicity evaluation, and preclinical studies


Antibody engineering services to help enhance pipeline speed

Thermo Fisher Scientific offers a range of services that support antibody engineering from early, high-throughput screening through scale-up as the number of candidates is narrowed. Invitrogen GeneArt services can help accelerate antibody research and development by offering reliable custom DNA and protein as you refine your antibody design.

Services for antibody engineering start with gene optimization, synthesis, and cloning, then continue through protein expression, purification, and antibody characterization


Select scale below to explore solutions for antibody engineering.

Featured resource for the antibody development workflow

Webinar: Unleashing the power of automation for high-throughput
antibody synthesis

Watch now


For Research Use Only. Not for use in diagnostic procedures.

Stylesheet for Classic Wide Template adjustments